48,466
edits
Difference between revisions of "Biphenotypic sinonasal sarcoma"
Jump to navigation
Jump to search
Biphenotypic sinonasal sarcoma (view source)
Revision as of 16:08, 13 March 2016
, 16:08, 13 March 2016→IHC
(create) |
(→IHC) |
||
| Line 20: | Line 20: | ||
*Actin +ve. | *Actin +ve. | ||
*S-100 +ve (strong). | *S-100 +ve (strong). | ||
==Molecular== | |||
*PAX3-MAML3 fusion - t(2;4)(q35;q31.1).<ref name=pmid24859338>{{Cite journal | last1 = Wang | first1 = X. | last2 = Bledsoe | first2 = KL. | last3 = Graham | first3 = RP. | last4 = Asmann | first4 = YW. | last5 = Viswanatha | first5 = DS. | last6 = Lewis | first6 = JE. | last7 = Lewis | first7 = JT. | last8 = Chou | first8 = MM. | last9 = Yaszemski | first9 = MJ. | title = Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. | journal = Nat Genet | volume = 46 | issue = 7 | pages = 666-8 | month = Jul | year = 2014 | doi = 10.1038/ng.2989 | PMID = 24859338 }}</ref> | |||
==See also== | ==See also== | ||